Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
Photo by Christina Victoria Craft on Unsplash
From BZ’s Small Cap Healthcare Conference: Enveric Biosciences Director & CEO, Dr. Joseph Tucker Begins Speaking
Click To Tune In Here... https://www.youtube.com/watch?v=TG5SSZDlpBo
4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga’s Healthcare Conference
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth.
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF
On Thursday, AdvisorShares launched the country’s first actively managed ETF covering the psychedelics sector.
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
The psychedelics sector has closed one of its largest M&As since its inception.
Meet The Top 12 CEOs In The Psychedelics Industry
By Natan Ponieman and Javier Hasse
The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.